OncoCyte Corp
OncoCyte Corp (OCX) is a publicly traded company in the Unknown sector. Across all available filings, 27 corporate insiders have executed 163 transactions totaling $127.0M, demonstrating a bullish sentiment with $94.2M in net insider flow. The most recent transaction on Apr 11, 2024 involved a purchase of 33,898 shares valued at $100.0K.
OCX Insider Activity Summary
Who Is Buying OCX Stock?
No significant insider buying has been recorded for OCX in the recent period.
Who Is Selling OCX Stock?
No significant insider selling has been recorded for OCX in the recent period.
Is OncoCyte Corp Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for OCX is bullish with an Insider Alignment Score of 87/100 and a net flow of $94.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
OCX Frequently Asked Questions
Understanding OCX Insider Activity
Insider trading at OncoCyte Corp (OCX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 27 insiders are actively trading OCX stock, having executed 163 transactions in the past 90 days. The most active insider is Ronald Asbury Andrews (Executive), who has made 14 transactions totaling $43.1M.
Related Tools
Track OncoCyte Corp Insider Activity
Get notified when executives and directors at OCX file new Form 4 transactions